Hewlett Packard Enterprise Co vs Nuwellis Inc — how do they compare? Hewlett Packard Enterprise Co trades at $71.99 (market cap $94.25B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Hewlett Packard Enterprise Co is far larger — about 42840.9× Nuwellis Inc's market cap, and Hewlett Packard Enterprise Co pays a 0.8% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hewlett Packard Enterprise Co for 33 Days and Nuwellis Inc for 26 Days on average.
| HPE | NUWE | |
|---|---|---|
Market Cap | $94.25B | $2.20M |
Volume | 16,060,854 | 121,544 |
Sector | Technology | Health |
52-Week High | $72.12 | $146.65 |
52-Week Low | $20.01 | $0.68 |
Typical Hold Time | 33 Days | 26 Days |
Enterprise Value | $108.28B | -$1.52M |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
HPE's stock is trading at $72.12, up 2.2% today and near its all-time high, driven by strong AI infrastructure demand. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $1.11 surpassing the $0.932 estimate. The company secured a $1.2 billion AI server order from Vultr and raised its networking outlook, fueling bullish technical signals and positive analyst sentiment.
The outlook remains optimistic due to AI-driven growth and raised revenue targets, but risks include high valuation multiples and volatile cash flows. With a consensus price target of $70.35, slightly below the current price, the stock faces potential near-term resistance despite strong fundamentals and institutional upgrades.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →